Zobrazeno 1 - 10
of 77
pro vyhledávání: '"Rin Yamaguchi"'
Publikováno v:
Nihon Hoshasen Gijutsu Gakkai zasshi. 78(10)
Autor:
Tsengelmaa Jamiyan, Rin Yamaguchi, A. Masunaga, H. Kuroda, A. Kakumoto, Akihito Abe, Oi Harada
Publikováno v:
Clinical & Translational Oncology
Purpose Immune cells such as cytotoxic T cells, helper T cells, B cells or tumor-associated macrophages (TAMs) contribute to the anti-tumor response or pro-tumorigenic effect in triple negative breast cancer (TNBC). The interrelation of TAMs, T and B
Autor:
Atsuko Masunaga, Akihito Abe, Rin Yamaguchi, Oi Harada, Hajime Kuroda, Akinari Kakumoto, Tsengelmaa Jamiyan
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-10 (2021)
BMC Cancer
BMC Cancer
Background In this study, we investigated CD20+ TILs in triple-negative breast cancer (TNBC) and their relationship with T lymphocyte subsets (CD4+, CD8+, CD25+, and FOXP3+), including their combined prognostic value using an immunohistochemical stai
Autor:
Hiroki Ueo, Itsushi Minoura, Hiroaki Ueo, Ayako Gamachi, Yuichiro Kai, Yoko Kubota, Takako Doi, Miki Yamaguchi, Toshinari Yamashita, Hitoshi Tsuda, Takuya Moriya, Rin Yamaguchi, Yuji Kozuka, Takeshi Sasaki, Takaaki Masuda, Yasuteru Urano, Masaki Mori, Koshi Mimori
Publikováno v:
Scientific Reports. 12
Breast-conserving surgery has become the preferred treatment method for breast cancer. Surgical margin assessment is performed during surgery, as it can reduce local recurrence in the preserved breast. Development of reliable and lower-cost ex vivo c
Autor:
Gábor Cserni, Edi Brogi, Hiram S. Cody, Rahul Deb, Gelareh Farshid, Sandra O'Toole, Elena Provenzano, Cecily M. Quinn, Aysegul A. Sahin, Fernando Schmitt, Donald L. Weaver, Rin Yamaguchi, Fleur Webster, Puay Hoon Tan
Publikováno v:
Archives of pathologylaboratory medicine. 146(11)
Context.— The International Collaboration on Cancer Reporting (ICCR), supported by major pathology and cancer organizations, aims at the standardization of evidence-based pathology reporting of different types of cancers, with the inclusion of all
Autor:
Isao Kitano, Kazumitsu Kiyomatsu, Ken Yamaguchi, Ryoko Egashira, Hiroyuki Irie, Takahiko Nakazono, Takahiro Hamamoto, Yukiko Hara, Fumio Yamasaki, Takeshi Imaizumi, Rin Yamaguchi
Publikováno v:
Breast Cancer. 28:572-580
Purpose of our study is to assess the relationship between MRI findings and invasive breast cancer (IBC) with cancer-associated fibroblasts (CAFs) that are positive for podoplanin. We retrospectively analyzed the consecutive 109 IBCs. The IBCs were d
Autor:
Hitoshi Obara, Hironori Kusano, Sachiko Ogasawara, Eiji Abe, Miki Yamaguchi, Hirohisa Yano, Rin Yamaguchi, Maki Tanaka, Jun Akiba, Yoshito Akagi, Momoko Akashi, Tatsuyuki Kakuma
Publikováno v:
Breast Cancer Research and Treatment. 184:277-285
Although HER2-positive (HER2+) invasive breast carcinomas (BC) have a different clinical therapeutic responsiveness according to estrogen and progesterone receptor expression, the relationship with androgen receptors (AR), which are the same family o
Publikováno v:
Virchows Archiv
Tumor-associated macrophages (TAMs) have recently been reported as an important factor in tumor growth and the progression of cancer. The prognostic significance of localizations and densities of TAMs in triple negative cancer (TNC) of the breast is
Prognostic impact of a tumor-infiltrating lymphocyte subtype in triple negative cancer of the breast
Autor:
Tsengelmaa Jamiyan, Masato Onozaki, Rin Yamaguchi, Yoshimasa Nakazato, Akihito Abe, Hajime Kuroda, Shuhei Noda, Mitsuhiro Hayashi
Publikováno v:
Breast Cancer (Tokyo, Japan)
BackgroundTumor-infiltrating lymphocytes (TILs) have recently been reported as an important factor in the tumor microenvironment and influence the growth and progression of cancer. However, the relationship between immune cell subpopulations, such as
Autor:
Momoko Akashi, Hitoshi Obara, Hirohisa Yano, Rin Yamaguchi, Jun Akiba, Uhi Toh, Maki Tanaka, Miki Yamaguchi, Tatsuyuki Kakuma, Yoshito Akagi, Hironori Kusano
Publikováno v:
Histopathology. 76:560-571
AIMS HER2-positive (HER2+) breast carcinoma (BC) cases are often treated similarly; however, they can be classified as either luminal B (LH) or non-luminal type (NLH) BC, which have different prognoses. In this study, we investigated the clinicohisto